THMO: thermogenesis.com Company Aggregate Debts

Public company logo of ThermoGenesis Holdings (THMO)

ThermoGenesis (THMO) leverages the expertise of a team of biomedical developers while strategically expanding its network of regional sales representatives. Management is betting on the robotization of CAR-T therapy to enhance clinic safety. This daily price chart on GURU.Markets shows debt at 0.00, which complements the brand image of a company recognized as the benchmark for precision when handling valuable biomaterials in laboratories.

thermogenesis.com - THMO Company Debts (period 07/04/2022 - 08/04/2024)

Comprehensive metric breakdowns and analytics for ThermoGenesis Holdings (THMO)

- price and consensus price forecast:
Market Chart Cesca Therapeutics|THMO - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization ThermoGenesis Holdings Inc.|THMO - Enterprise Value
- book capitalization data:
Book Value of One Share ThermoGenesis|THMO - Company Book Value|Capitalization to Book Value Ratio thermogenesis.com|THMO - Aggregate Company Assets
- debt and liquidity data:
Debt to Capital ThermoGenesis|THMO - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient ThermoGenesis Holdings, Inc.|THMO - Company Total Debt|Debt to Book Capital ThermoGenesis Holdings Inc.
Comprehensive company analysis:THMO Cesca Therapeutics
Product sample of ThermoGenesis Holdings Inc.

Assessing the financial stability of ThermoGenesis requires an analysis of total external liabilities relative to available liquidity to minimize portfolio risks. This real-time assessment of leverage captures the dynamics of the credit load, which is critical when utilizing medtech manufacturing outsourcing and international logistics, where operating expenses depend directly on the efficiency of debt management.

Key competitors

Company Total Debt Obligations Abbott Corp. (ABT)|Company Aggregate Debts TMO (Thermo Fisher Scientific)|Company Aggregate Debts gehealthcare.com GEHC|Company Aggregate Debts MTD|WAT: Company Total Indebtedness|Company Debts Techne Corporation|BRKR (Bruker BioSpin) - Company Aggregate Debt|Company Debts AZTA (Azenta, Inc.)|Company Cumulative Debt VREX|SMLR (Semler Scientific) - Company Debts|Company Total Debt Obligations Butterfly Network Inc BFLY|Company Total Debt Mesa Labs Corp (MLAB)|Company Cumulative Indebtedness Quantum-Si Corporation QSI|Company Aggregate Debts NNOX (Nano-X Imaging Ltd.)|QTRX - Company Total Debt Obligations|MASS (908 Devices) - Company Aggregate Debts|Company Total Debt CapsoVision|MXCT - Company Total Debt|Aggregate Debt Obligations RPID|Company Debts SEER (Seer, Inc.)|Company Total Debt hyperfine.io (HYPR)|FONR: Company Aggregate Debts|Company Cumulative Debt Daxor Corp DXR|Spectral AI (MDAI) - Company Aggregate Debts|VIVS - Company Aggregate Debt|Aclarion - Company Aggregate Debts|Akoya Biosciences, Inc. (AKYA) - Company Total Debt Obligations|Company Aggregate Debts TLIS|Company Total Debt T2 Biosystems Inc.